ELV
Elevance Health Inc.
NYSE · USHealthcareMedical - Healthcare Plans
$382.23+2.44%
Price as of Jul 20, 2026
ELV financials
Elevance Health Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $199.1B | $176.8B | $171.3B | $156.6B |
| Cost of revenue | $148.2B | $127.6B | $124.3B | $116.6B |
| Gross profit | $50.9B | $49.2B | $47.0B | $40.0B |
| Operating expenses | $42.8B | $40.4B | $38.3B | $31.5B |
| Operating income | $8.1B | $8.9B | $8.7B | $8.5B |
| Net income | $5.7B | $6.0B | $6.0B | $5.9B |
| EBITDA | $9.7B | $10.5B | $10.5B | $10.1B |
| Basic EPS | $25.18 | $25.81 | $25.38 | $24.56 |
| Diluted EPS | $25.12 | $25.68 | $25.22 | $24.28 |
| Balance sheet | ||||
| Cash & equivalents | $9.5B | $8.3B | $6.5B | $7.4B |
| Total assets | $121.5B | $116.9B | $108.9B | $102.8B |
| Total liabilities | $77.5B | $75.5B | $69.5B | $66.4B |
| Stockholders’ equity | $43.9B | $41.3B | $39.3B | $36.2B |
| Total debt | $33.2B | $32.7B | $26.7B | $25.8B |
| Net debt | $23.7B | $24.4B | $20.1B | $18.4B |
| Cash flow | ||||
| Operating cash flow | $4.3B | $5.8B | $8.1B | $8.4B |
| Capital expenditure | -$1.1B | -$1.3B | -$1.3B | -$1.2B |
| Free cash flow | $3.2B | $4.6B | $6.8B | $7.2B |
| Dividends paid | -$1.5B | -$1.5B | -$1.4B | -$1.2B |
| Share repurchases | -$2.6B | -$2.9B | -$2.7B | -$2.3B |